minimal essential media non-essential amino acid solution (mem-neaa) (Thermo Fisher)
90
Structured Review
Thermo Fisher
minimal essential media non-essential amino acid solution (mem-neaa)
Minimal Essential Media Non Essential Amino Acid Solution (Mem Neaa), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/minimal+essential+media+(mem)+non-essential+amino+acids+(neaa/minimum+essential+medium+non+essential+amino+acids/10__3390_slash_mps7060099-62-50-60
Average 90 stars, based on 1 article reviews
Minimal Essential Media Non Essential Amino Acid Solution (Mem Neaa), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/minimal+essential+media+(mem)+non-essential+amino+acids+(neaa/minimum+essential+medium+non+essential+amino+acids/10__3390_slash_mps7060099-62-50-60
Average 90 stars, based on 1 article reviews
minimal essential media non-essential amino acid solution (mem-neaa) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Cell Culture:Article Title: Nanoscale physicochemical properties of chain- and step-growth polymerized PEG hydrogels affect cell-material interactions. Article Snippet: Penicillin/Streptomycin/Amphotericin B was purchased from Lonza, L-glutamine, Dulbecco’s Modified Eagle Media (DMEM) and Article Title: Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia. Article Snippet: Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia Wenxia Zhang, Cuicui Liu, Dan Wu, Chen Liang, Leisheng Zhang, Qiuqiu Zhang, Yiying Liu, Meijuan Xia, Hongtao Wang, Pei Su, Sizhou Feng, Mingzhe Han, Jiaxi Zhou, Fuxu Wang, Erlie Jiang PII: S1079-9796(18)30453-4 DOI: https://doi.org/10.1016/j.bcmd.2019.02.003 Reference: YBCMD 2309 To appear in: Blood Cells, Molecules and Diseases Received date: 5 December 2018 Revised date: 2 February 2019 Accepted date: 17 February 2019 Please cite this article as: W. Zhang, C. Liu, D. Wu, et al., Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia, Blood Cells, Molecules and Diseases, https://doi.org/10.1016/j.bcmd.2019.02.003 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Modification:Article Title: Nanoscale physicochemical properties of chain- and step-growth polymerized PEG hydrogels affect cell-material interactions. Article Snippet: Penicillin/Streptomycin/Amphotericin B was purchased from Lonza, L-glutamine, Dulbecco’s Modified Eagle Media (DMEM) and Article Title: Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia. Article Snippet: Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia Wenxia Zhang, Cuicui Liu, Dan Wu, Chen Liang, Leisheng Zhang, Qiuqiu Zhang, Yiying Liu, Meijuan Xia, Hongtao Wang, Pei Su, Sizhou Feng, Mingzhe Han, Jiaxi Zhou, Fuxu Wang, Erlie Jiang PII: S1079-9796(18)30453-4 DOI: https://doi.org/10.1016/j.bcmd.2019.02.003 Reference: YBCMD 2309 To appear in: Blood Cells, Molecules and Diseases Received date: 5 December 2018 Revised date: 2 February 2019 Accepted date: 17 February 2019 Please cite this article as: W. Zhang, C. Liu, D. Wu, et al., Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia, Blood Cells, Molecules and Diseases, https://doi.org/10.1016/j.bcmd.2019.02.003 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. |